Skip to main content
Home > BioCentury on BioBusiness > Analysts

Chronological Index of BioCentury, The Bernstein Report on BioBusiness: Analyst Picks & Changes

BioCentury, The Bernstein Report on BioBusiness Current Issue
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 11/2 cls Charles River Laboratories International Inc. (NYSE:CRL) Jefferies David Windley Price target Hold 0% $39.44 Windley raised …

    Published on 11/5/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/26 cls Amgen Inc. (NASDAQ:AMGN) BMO Capital Markets Jim Birchenough Price target Market perform 1% $87.63 Deutsche Bank Robyn …

    Published on 10/29/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/19 cls Aegerion Pharmaceuticals Inc. (NASDAQ:AEGR) Deutsche Bank Robyn Karnauskas Price target Buy 23% 19.6 Jefferies Eun Yang …

    Published on 10/22/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/12 cls Aveo Pharmaceuticals Inc. (NASDAQ:AVEO) Leerink Howard Liang Downgrade Market perform (from outperform) -20% $7.98 Liang …

    Published on 10/15/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 10/5 cls Amarin Corp. plc (NASDAQ:AMRN) Wedbush Akiva Felt Downgrade Neutral (from outperform) 0% $12.52 Felt also lowered his target…

    Published on 10/8/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/28 cls Peregrine Pharmaceuticals Inc. (NASDAQ:PPHM) MLV George Zavoico Downgrade Hold (from buy) -81% $1.03 Roth Capital Partners …

    Published on 10/1/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/21 cls Abbott Laboratories (NYSE:ABT) Jefferies Jeffrey Holford Price target Buy 2% $69.62 Holford raised his target to $85 from $…

    Published on 9/24/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/14 cls Amgen Inc. (NASDAQ:AMGN) Baird Christopher Raymond Downgrade Neutral (from outperform) -3% $81.36 Raymond said Amgen's story…

    Published on 9/17/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 9/7 cls Addex Therapeutics Ltd. (SIX:ADXN) Wedbush Christopher Marai New Outperform 21% CHF9.20 Marai set a CHF28 target. He believes…

    Published on 9/10/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/31 cls Affymax Inc. (NASDAQ:AFFY) MLV Ed Arce Price target Buy 3% $17.69 Arce raised his target to $26 from $21, saying the Street …

    Published on 9/3/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/24 cls Aastrom Biosciences Inc. (NASDAQ:ASTM) Roth Capital Partners Joseph Pantginis Downgrade Neutral (from buy) -12% $1.60 …

    Published on 8/27/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/17 cls Array BioPharma Inc. (NASDAQ:ARRY) Leerink Howard Liang Upgrade Outperform (from market perform) 21% $5.50 Liang also raised…

    Published on 8/20/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/10 cls Elan Corp. plc (NYSE:ELN) RBC Capital Markets Michael Yee Other Outperform -2% $11.10 Yee believes Elan needs to think about…

    Published on 8/13/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 8/3 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Leerink Joseph Schwartz Downgrade Market perform (from outperform) -9% $24.18 …

    Published on 8/6/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/27 cls Alexion Pharmaceuticals Inc. (NASDAQ:ALXN) Deutsche Bank Robyn Karnauskas Price target Buy 10% $108.97 Jefferies Eun Yang …

    Published on 7/30/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/20 cls Infinity Pharmaceuticals Inc. (NASDAQ:INFI) Piper Jaffray Edward Tenthoff Price target Neutral 0% $15.68 Tenthoff raised his…

    Published on 7/23/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/13 cls Biogen Idec Inc. (NASDAQ:BIIB) Stifel Nicolaus Weisel Joel Sendek Price target Buy 2% $144.61 Sendek raised his target to $…

    Published on 7/16/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 7/6 cls Affymetrix Inc. (NASDAQ:AFFX) Goldman Sachs Isaac Ro Downgrade Sell (from neutral) -3% $4.54 Ro also lowered his target to $4…

    Published on 7/9/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/29 cls Arena Pharmaceuticals Inc. (NASDAQ:ARNA) BMO Capital Markets Jim Birchenough Price target Market perform 1% $9.98 Jefferies…

    Published on 7/2/2012
  • Analyst picks and changes

    Analyst picks and changes Company Bank Analyst Coverage Opinion Wk chg 6/22 cls Celgene Corp. (NASDAQ:CELG) Baird Christopher Raymond Price target Outperform -7% $61.63 Barclays Capital Ying Huang …

    Published on 6/25/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/15 cls Basilea Pharmaceutica AG (SIX:BSLN) Jefferies Philippa Gardner Price target Hold 3% CHF44.05 Gardner raised her target to …

    Published on 6/18/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/8 cls Auxilium Pharmaceuticals Inc. (NASDAQ:AUXL) Jefferies Thomas Wei Price target Buy 14% $21.57 Leerink Joseph Schwartz …

    Published on 6/11/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 6/1 cls Amylin Pharmaceuticals Inc. (NASDAQ:AMLN) Baird Thomas Russo Downgrade Neutral (from overweight) -4% $26.73 Russo downgraded …

    Published on 6/4/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/25 cls Affymax Inc. (NASDAQ:AFFY) MLV Ed Arce Price target Buy 8% $14.07 Arce raised his target to $21 from $12 after Affymax and …

    Published on 5/28/2012
  • Analyst picks & changes

    Analyst picks & changes Company Bank Analyst Coverage Opinion Wk chg 5/18 cls AMAG Pharmaceuticals Inc. (NASDAQ:AMAG) Ladenburg Thalmann Juan Sanchez Upgrade Buy (from neutral) -1% $13.14 Sanchez set a…

    Published on 5/21/2012

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993

Log In


Forgot password  |  Forgot Login


If you are a subscriber, but have forgotten or never received a password, please click above to receive a new one.

BioCentury on BioBusiness

BioCentury, The Bernstein Report on BioBusiness is globally recognized for industry analysis, interpretation and commentary on:

  • Corporate Strategy
  • Product Discovery and Development
  • Finance
  • Emerging Companies
  • Regulatory Policy
  • Public Policy
Need custom ComputerVision Software?